FI873553A7 - HIV-infektioiden hoitoon ja diagnostisointiin käyttökelpoisia monoklonaalisia vasta-aineita ja peptidejä - Google Patents

HIV-infektioiden hoitoon ja diagnostisointiin käyttökelpoisia monoklonaalisia vasta-aineita ja peptidejä Download PDF

Info

Publication number
FI873553A7
FI873553A7 FI873553A FI873553A FI873553A7 FI 873553 A7 FI873553 A7 FI 873553A7 FI 873553 A FI873553 A FI 873553A FI 873553 A FI873553 A FI 873553A FI 873553 A7 FI873553 A7 FI 873553A7
Authority
FI
Finland
Prior art keywords
diagnosis
treatment
monoclonal antibodies
hiv infections
peptides useful
Prior art date
Application number
FI873553A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI873553L (fi
FI873553A0 (fi
Inventor
Mary K Shriver
Edna S Dickinson
Janela Mcclure
Elaine K Thomas
Wesley L Cosand
George J Todaro
Robert C Nowinski
Original Assignee
Genetic Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetic Systems Corp filed Critical Genetic Systems Corp
Publication of FI873553A0 publication Critical patent/FI873553A0/fi
Publication of FI873553L publication Critical patent/FI873553L/fi
Publication of FI873553A7 publication Critical patent/FI873553A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
    • F04B—POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS
    • F04B25/00—Multi-stage pumps
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1054—Lentiviridae, e.g. HIV, FIV, SIV gag-pol, e.g. p17, p24
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • AIDS & HIV (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mechanical Engineering (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI873553A 1986-08-20 1987-08-17 HIV-infektioiden hoitoon ja diagnostisointiin käyttökelpoisia monoklonaalisia vasta-aineita ja peptidejä FI873553A7 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89827386A 1986-08-20 1986-08-20
US4502687A 1987-05-01 1987-05-01
US6799687A 1987-06-29 1987-06-29

Publications (3)

Publication Number Publication Date
FI873553A0 FI873553A0 (fi) 1987-08-17
FI873553L FI873553L (fi) 1988-02-21
FI873553A7 true FI873553A7 (fi) 1988-02-21

Family

ID=27366600

Family Applications (1)

Application Number Title Priority Date Filing Date
FI873553A FI873553A7 (fi) 1986-08-20 1987-08-17 HIV-infektioiden hoitoon ja diagnostisointiin käyttökelpoisia monoklonaalisia vasta-aineita ja peptidejä

Country Status (28)

Country Link
JP (1) JPS6485928A (enrdf_load_stackoverflow)
KR (1) KR920008744B1 (enrdf_load_stackoverflow)
AT (1) AT398080B (enrdf_load_stackoverflow)
AU (1) AU616156B2 (enrdf_load_stackoverflow)
BE (1) BE1000811A4 (enrdf_load_stackoverflow)
CH (1) CH675728A5 (enrdf_load_stackoverflow)
CS (1) CS275838B6 (enrdf_load_stackoverflow)
DE (1) DE3727703A1 (enrdf_load_stackoverflow)
DK (1) DK433087A (enrdf_load_stackoverflow)
ES (1) ES2010727A6 (enrdf_load_stackoverflow)
FI (1) FI873553A7 (enrdf_load_stackoverflow)
FR (1) FR2603107B1 (enrdf_load_stackoverflow)
GB (1) GB2196634B (enrdf_load_stackoverflow)
GR (1) GR871298B (enrdf_load_stackoverflow)
HU (1) HU214439B (enrdf_load_stackoverflow)
IE (1) IE60671B1 (enrdf_load_stackoverflow)
IL (1) IL83580A (enrdf_load_stackoverflow)
IT (1) IT1222518B (enrdf_load_stackoverflow)
LU (1) LU86972A1 (enrdf_load_stackoverflow)
NL (1) NL8701950A (enrdf_load_stackoverflow)
NO (2) NO300462B1 (enrdf_load_stackoverflow)
NZ (1) NZ221440A (enrdf_load_stackoverflow)
OA (1) OA08652A (enrdf_load_stackoverflow)
PL (1) PL155084B1 (enrdf_load_stackoverflow)
PT (1) PT85567B (enrdf_load_stackoverflow)
SE (1) SE506025C2 (enrdf_load_stackoverflow)
YU (1) YU152587A (enrdf_load_stackoverflow)
ZW (1) ZW15487A1 (enrdf_load_stackoverflow)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP96A (en) * 1986-06-03 1990-08-12 The Usa Dept Of Commerce Small peptides which inhibit binding to T-4 receptors and act as immunogens.
AU625720B2 (en) * 1987-05-01 1992-07-16 Genetic Systems Corporation Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use
US6657050B1 (en) 1987-05-29 2003-12-02 Tanox, Inc. Chimeric viral-neutralizing immunoglobulins
US5834599A (en) * 1987-05-29 1998-11-10 Tanox Biosystems, Inc. Immunoconjugates which neutralize HIV-1 infection
US5981278A (en) * 1987-05-29 1999-11-09 Tanox, Inc. Chimeric monoclonal antibodies which neutralize HIV-1 infection and their applications in therapy and prevention for AIDS
DE3853779T2 (de) * 1987-05-29 1995-09-07 Baylor College Medicine Hiv-1 neutralisierende monoklonale antikörper.
EP0400076B1 (en) * 1988-01-26 1996-05-15 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce A synthetic antigen evoking anti-hiv response
CA1341285C (en) * 1988-02-12 2001-08-14 Chang Yi Wang Synthetic peptides for the detection of antibodies to hiv gp120 envelope protein for diagnosis of aids and pre-aids conditions and as vaccines
IL90048A0 (en) * 1988-04-25 1989-12-15 Merck & Co Inc Recombinant gag precursor of hiv,its preparation and its use as aids vaccine
US5562905A (en) * 1988-04-26 1996-10-08 E. I. Du Pont De Nemours And Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
EP0339504A3 (en) * 1988-04-26 1990-09-12 The Du Pont Merck Pharmaceutical Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
FR2632310B1 (fr) * 1988-06-06 1992-04-10 Pasteur Institut Peptides ayant des proprietes protectrices d'un virus pathogene du type hiv dans des cellules sensibles
FI911574A7 (fi) * 1988-10-03 1991-04-02 Repligen Corp Uusia HIV-proteiineja ja -peptidejä, jotka ovat käyttökelpoisia aidsin toteamisessa, ennaltaehkäisyssä ja hoidossa
EP0421626A1 (en) * 1989-09-19 1991-04-10 Merck & Co. Inc. Vaccine for aids and hepatitis B
SE9000333D0 (sv) * 1990-01-31 1990-01-31 Britta Wahren Monoklonal antikropp
SE468168B (sv) * 1990-02-20 1992-11-16 Replico Medical Ab Hiv-1, p24 peptider, diagnostiska antigener och foerfarande foer saerskiljande diagnostik av preliminaert hiv-1 positiva serumprov
JPH03271233A (ja) * 1990-03-19 1991-12-03 Inst Pasteur ウイルスエンベロープ糖タンパク質及びその糖タンパク質の中和エピトープに対応するペプチドの間の相乗作用による、ウイルス性感染に対する防御の誘発
CA2047078A1 (en) * 1990-07-19 1992-01-20 Steven S. Bondy Cyclic hiv principal neutralizing determinant peptides
CA2047042A1 (en) * 1990-07-19 1992-01-20 John Hannah Cyclic hiv principal neutralizing determinant peptides
JPH05310785A (ja) * 1991-09-30 1993-11-22 Nitto Denko Corp Ｈｉｖ関連環状ペプチドおよびこれを固定化した吸着体
DK0960886T3 (da) * 1992-03-27 2004-09-27 Advanced Immuni T Inc Peptid T og beslægtede peptider til behandling af inflammation, herunder multipel sklerose
NZ569401A (en) 2005-12-09 2012-03-30 Vectus Biosystems Ltd VIP fragments and methods of use
US8253311B2 (en) 2008-09-02 2012-08-28 Ngk Spark Plug Co., Ltd Spark plug
KR102727239B1 (ko) * 2022-09-07 2024-11-07 한국세라믹기술원 산화 마그네슘　분말 및 그의 제조방법

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9328391B1 (en) * 1984-08-22 2016-05-03 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Cloning and expression of HIV-1 DNA
GB8501473D0 (en) * 1985-01-21 1985-02-20 Pasteur Institut Cloned dna sequences
DE3588254T2 (de) * 1984-10-18 2008-06-26 Institut Pasteur GAG-Antigen und dessen Verwendung zum Nachweis von LAV-Infektion, sowie in immunogenen Zusammensetzungen
CA1341423C (en) * 1984-10-31 2003-03-04 Paul A. Luciw Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
GR860915B (en) * 1985-04-08 1986-07-11 Genetic Systems Corp Expression and diagnostic use of gag encoded peptides which are immunologically reactive with antibodies to lav
IE64785B1 (en) * 1985-04-08 1995-09-06 Genetic Systems Corp Expression of immunologically reactive viral proteins
NZ215867A (en) * 1985-04-19 1989-10-27 Hoffmann La Roche Aids envelope protein, dna vectors and method of production
KR910002374B1 (ko) * 1985-04-29 1991-04-20 제네틱 시스템즈 코포레이션 Aids 관련질병의 검출을 위한 합성항원
GB8525615D0 (en) * 1985-10-17 1985-11-20 Hoffmann La Roche Polypeptides
DE3689941D1 (de) * 1985-10-24 1994-08-04 Southwest Found Biomed Res Synthetische peptide und deren verwendung zur diagnose und impfung für aids und arc.
JP2837669B2 (ja) * 1985-11-07 1998-12-16 プレジデント アンド フエロウズ オブ ハ−バ−ド カレツジ Ｔ−細胞リンパ趨行性ウイルス蛋白及びその分析
US4772547A (en) * 1986-02-03 1988-09-20 Hoffmann-La Roche Inc. HTLV-III envelope peptides
US4734362A (en) * 1986-02-03 1988-03-29 Cambridge Bioscience Corporation Process for purifying recombinant proteins, and products thereof
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
IE63109B1 (en) * 1986-06-23 1995-03-22 Genetic Systems Corp Human monoclonal antibody to lymphadenopathy-associated virus
EP0255190A3 (en) * 1986-08-01 1990-08-29 Repligen Corporation Recombinant polypeptides and their uses, inclusing assay for aids virus
AU592258B2 (en) * 1986-12-30 1990-01-04 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Synthetic peptides which induce cellular immunity to the aids virus and aids viral proteins

Also Published As

Publication number Publication date
PT85567B (pt) 1991-02-08
KR920008744B1 (ko) 1992-10-09
YU152587A (sh) 1992-09-07
NO934897D0 (no) 1993-12-29
HU214439B (hu) 1998-03-30
HUT44619A (en) 1988-03-28
CS275838B6 (en) 1992-03-18
GB2196634B (en) 1991-05-15
NO300462B1 (no) 1997-06-02
LU86972A1 (fr) 1988-03-02
PL267401A1 (en) 1988-07-21
FI873553L (fi) 1988-02-21
NO934897L (no) 1993-12-29
CS8706136A2 (en) 1990-08-14
SE506025C2 (sv) 1997-11-03
IT8721678A0 (it) 1987-08-19
NZ221440A (en) 1991-11-26
AU616156B2 (en) 1991-10-24
ATA208987A (de) 1994-01-15
KR890002547A (ko) 1989-04-10
PT85567A (en) 1987-09-01
FI873553A0 (fi) 1987-08-17
DE3727703A1 (de) 1988-05-05
IE872219L (en) 1988-02-20
IL83580A0 (en) 1988-01-31
GR871298B (en) 1988-01-12
NL8701950A (nl) 1988-03-16
AU7720187A (en) 1988-05-19
SE8703225L (sv) 1988-02-21
GB2196634A (en) 1988-05-05
NO302176B1 (no) 1998-02-02
ES2010727A6 (es) 1989-12-01
IT1222518B (it) 1990-09-05
NO873495L (no) 1988-02-22
FR2603107A1 (fr) 1988-02-26
ZW15487A1 (en) 1988-09-14
NO873495D0 (no) 1987-08-19
PL155084B1 (en) 1991-10-31
DK433087D0 (da) 1987-08-19
IL83580A (en) 1992-11-15
AT398080B (de) 1994-09-26
OA08652A (fr) 1988-11-30
FR2603107B1 (fr) 1992-04-24
GB8719587D0 (en) 1987-09-23
DK433087A (da) 1988-02-21
IE60671B1 (en) 1994-08-10
JPS6485928A (en) 1989-03-30
CH675728A5 (enrdf_load_stackoverflow) 1990-10-31
BE1000811A4 (fr) 1989-04-11
SE8703225D0 (sv) 1987-08-19

Similar Documents

Publication Publication Date Title
FI873553A7 (fi) HIV-infektioiden hoitoon ja diagnostisointiin käyttökelpoisia monoklonaalisia vasta-aineita ja peptidejä
FI882173A7 (fi) Synteettinen peptidiantigeeni HIV-2-tartunnan toteamiseksi.
FI925631A7 (fi) Monoklonaaliset vasta-aineet
FI881418A7 (fi) Synteettiset peptidiantigeenit HIV-1 -infektion toteamiseksi.
DE3872754D1 (de) Nachweis von antikoerpern humaner immundefizienz-viren.
IT1207589B (it) Composizione di anticorpi monoclonali umani cross-protettivi.
FI944561A7 (fi) HIV:tä neutraloivia monoklonaalisia yhdistelmähumaanivasta-aineita HIV -infektion ehkäisemiseksi ja hoitamiseksi
FI915702A7 (fi) Peptidejä ja niistä johdettuja vasta-aineita HTLV-1 infektion vastaise n rokotuksen määrittämiseksi
KR890700683A (ko) 인체 면역 결핍 바이러스에 대한 항체 검색 방법
FI873606A7 (fi) Ihmisen glykoalbumiinin määrittämiseen käyttökelpoisia vasta-aineita.
FI874273L (fi) Uudet monoklonaaliset vasta-aineet IFN-omegalle, niiden valmistusmenetelmät ja niiden käyttö IFN-omegan puhdistamiseen ja osoittamiseen
FI894551A7 (fi) Hybridiset monoklonaaliset vasta-aineet, niiden valmistus ja käyttö
DE3687542D1 (de) Monoklonaler antikoerper gegen humanes protein c.
PT88077A (pt) Anticorpos monoclonais e metodos para o diagnostico de infeccao por phytophthora
FI872363A7 (fi) Bakteriosiinit ja niitä sisältävät koostumukset virusinfektioiden detektioon ja hoitoon.
NO872633L (no) Monoklonalt antistoff mot humant plasminogen, samt fremstilling derav.
FI875475A7 (fi) Hiiren hybridoma Lym-1 ja sillä tuotettu diagnostinen vasta-aine.
AU1508088A (en) Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use
FI875476A7 (fi) Hiiren hybridoma Lym-2 ja sillä tuotettu diagnostinen vasta-aine.
NO941347D0 (no) Fremgangsmåte for fremstilling av et humant monoklonalt antistoff

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: GENETIC SYSTEMS CORPORATION